Search results
Subscribe- Long Term Emcure Pharmaceuticals Ltd; Anand Rathi
CNBC Awaaz· 7 days agoAnand Rathi, has come out with its report on Emcure Pharmaceuticals Ltd. The research firm has recommended to “ Subscribe- Long Term” the ipo in its research report as on July 02 2024.